- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05739721
ZOOM First Impressions
Effects of Video Conferencing on First Impressions and Attractiveness
Participants (random) will have a conversation with each other over zoom initially with their cameras off and then rate each other on attractiveness, first impressions, and self-esteem. Then both participants will turn their cameras back on and have another conversion and then again rate each other. The ratings are confidential and will not be shared with the other person.
Two months later the participants will come to the study clinic office and have an in-person conversation with someone new and rate each other.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- DeNova Research
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Males and females of ages 21-39.
- Subjects that understand the purpose and aspects of the study, freely sign the consent and complete the required treatment and follow up visit.
- Subjects must all be able to speak English fluently.
- Subjects must have access to video camera technology.
- Fully Vaccinated against covid-19
Exclusion Criteria:
- Participants younger than 21 or older than 40 will not be included.
- Subjects who are pregnant or nursing.
- Imprisoned populations.
- Subjects who are unable to travel to the clinic.
- Subjects that do not understand the purpose and aspects of the study, do not sign the consent and do not complete the required virtual session and follow-up visit will also be excluded.
- Any subject that is not fully vaccinated against covid-19
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Zoom meeting (camera off)
participants will be randomly assigned to a Zoom (San Jose, CA, USA) video conference meeting with another participant of the opposite gender
|
Visual attractiveness scale 0-7
Self Esteem scale
Trustworthiness scale 0-7
|
Experimental: In person meeting (blindfolded)
Once all subjects have been selected and enrolled in the study, participants will be randomly assigned for an in-person meeting.
|
Visual attractiveness scale 0-7
Self Esteem scale
Trustworthiness scale 0-7
|
Experimental: Zoom meeting (camera on)
participants will be randomly assigned to a Zoom (San Jose, CA, USA) video conference meeting with another participant of the opposite gender
|
Visual attractiveness scale 0-7
Self Esteem scale
Trustworthiness scale 0-7
|
Experimental: In person meeting (no blindfold)
Once all subjects have been selected and enrolled in the study, participants will be randomly assigned for an in-person meeting.
|
Visual attractiveness scale 0-7
Self Esteem scale
Trustworthiness scale 0-7
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
First Impressions
Time Frame: 8 weeks
|
The defined categories of first impressions include: Social skills, academic performance, dating success, occupational success, attractiveness, financial success, relationship success, and athletic success.
The scale ranges from a score of 1 (less desirable) to 10 (most desirable).
Scores closer to 10 signify a more positive outcome.
|
8 weeks
|
Trustworthiness scale
Time Frame: 8 weeks
|
Scale 0 (disagree) - 7 (agree).
Scores closer to 7 signify a more positive outcome.
|
8 weeks
|
Overall Attractiveness
Time Frame: 8 weeks
|
Scale 0 (disagree) - 7 (agree).
Scores closer to 7 signify a more positive outcome.
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Self-Esteem
Time Frame: 8 weeks
|
The Rosenberg Self-Esteem Scale is a 10-item self-report measure of global self-esteem.
It consists of 10 statements related to overall feelings of self-worth or self-acceptance.
The items are answered on a four-point scale ranging from strongly agree, agree, disagree, and strongly disagree.
|
8 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- ZOOM-SD-2021
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Self Esteem
-
Université de Reims Champagne-ArdenneRecruiting
-
Loma Linda UniversityCompleted
-
Linkoeping UniversityCompleted
-
University of BarcelonaUniversitat Autonoma de Barcelona; European UnionRecruitingSelf-Perception | Self Esteem | SelfSpain
-
GGZ Noord-Holland-NoordRecruiting
-
VU University of AmsterdamLeiden University; University of Amsterdam; Maastricht University; Utrecht University and other collaboratorsEnrolling by invitation
-
McGill UniversityCompleted
-
Linkoeping UniversityCompleted
-
West University of TimisoaraCompleted
-
The University of Hong KongCompletedSelf-esteem | Family Relationship | Self-efficacyChina